Aequs Limited Clarifies Employee Stock Option Plan Details Following Shareholder Feedback
Aequs Limited announced on March 23, 2026, additional information regarding the ratification and amendment of its Aequs Employee Stock Option Plan 2025 (ESOP 2025) following feedback from proxy advisors. The clarification was provided in reference to a postal ballot notice previously issued on February 25, 2026.The company addressed concerns regarding the exercise price and vesting criteria outlined in the ESOP 2025. Aequs clarified that the exercise price for all grants under the plan will be the last traded price of equity shares of Aequs Limited on the recognized stock exchange with the highest trading volume on the day preceding the grant date.
Regarding vesting criteria, the company follows a combination of time-based and performance-based vesting. Historically, the majority of grants vest 50% over five years, with 10% vesting each year. The remaining options vest based on performance criteria such as revenue, EBITDA, and PAT targets. The vesting period typically falls within a range of 5-7 years.
The ESOP 2025 is administered under the supervision of the Nomination and Remuneration Committee and operates in accordance with the Companies Act, 2013 and the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Additional information can be accessed on the company’s website at https://www.aequs.com/investor/.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.